Picture Health unlocks the power of medical imaging with novel AI tools, providing enhanced analysis and insights for cancer diagnosis, prognosis, treatment selection, and tumor monitoring. Px turns routine clinical images into a rich data source, revealing new insights and maximizing the potential of every pixel. We designed Picture Health specifically to support radiologists, pathologists, and oncologists in providing the best care to cancer patients.
Proven
Tech:
25
Patents
52+
Papers & Abstracts

Picture Health unlocks the power of medical imaging with novel AI tools, providing enhanced analysis and insights for cancer diagnosis, prognosis, treatment selection, and tumor monitoring. Px turns routine clinical images into a rich data source, revealing new insights and maximizing the potential of every pixel. We designed Picture Health specifically to support radiologists, pathologists, and oncologists in providing the best care to cancer patients.

Proven Tech:
25 Patents
52+ Papers & Abstracts
Why Picture Health?

Shorter Turnaround Time
Px AI provides insights in minutes without additional lab tests.

Routine Clinical Images
We use images you already have, so your workflow stays the same.

Radiology & Pathology
We use different images: pathology WSI's, radiology CT scans, or the fusion of both.

Real-time Guidance
Our AI provides actionable information to the clinician.
What's Px?
Px is a new concept building on a decade of scientific research which utilizes imaging data more effectively. It takes advantage of the latest advancements in digitization and AI to analyze voxel/pixel-level data to provide new insights into the tumor and its surrounding environment. This powerful tool can help doctors make more well-informed decisions about their patient’s care. And the best part is, these images are routinely available and don’t require any separate orders or changes to your existing workflows. Px is a valuable addition to any diagnostic arsenal.
News
-
ASCO Abstract, Abstract
Association of single-click radiomic classifier with response and prognosis in non-small cell lung cancers (NSCLC) treated with immune checkpoint inhibitors
Published on: 06/09/2023
-
Precision Oncology News
Picture Health Sees Commercial Test Potential in Blood Vessel Twistedness Biomarker
Published on: 03/09/2023
-
Cision PR Newswire
Cancer Biomarkers With a Twist?
Published on: 03/09/2023
-
Oncology Issues
AI’s Role in Advancing Cancer Prevention: Detection, Diagnosis, Treatment, and Precision Medicine
Published on: 02/02/2023
-
National Cancer Institute
Tumor Twistedness Serves as AI-Based Biomarker for Lung Cancer Immunotherapy
Published on: 01/18/2023
